article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 161
article thumbnail

TechCrunch+ roundup: New VC rules, AI biotech investor survey, Instagram ad case study

TechCrunch

6 investors discuss why AI is more than just a buzzword in biotech. In her latest investor survey, Anna Heim spoke to six biotech investors about where AI creates value, short-term market shifts, and how they’d like to be approached by founders: Robert Mittendorff, M.D, general partner and head of healthcare, B Capital.

Biotech 215
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Life Sciences Executive Search Firms: Bridging Biotech and Leadership

N2Growth Blog

The Importance of Executive Search and Leadership Development to the Growth of the Life Sciences Industry Ensuring that organizations have access to top talent for key leadership positions and that talent is sufficiently supported and developed is critical to the growth of the life sciences industry.

Biotech 94
article thumbnail

How WhiteLab Genomics is using AI to aid gene and cell therapy development

TechCrunch

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. However, such therapies are typically costly to develop with no guarantee that they’ll work.

Biotech 258
article thumbnail

Cradle’s AI-powered protein programming platform levels up with $24M in new funding

TechCrunch

Biotech and AI startup Cradle is finding success with its generative approach to protein design, landing big customers and a hefty $24 million of new investment. Many AI companies in biotech train models […] © 2023 TechCrunch.

Biotech 280
article thumbnail

Form Bio says now is the time to launch — despite cooling software sales

TechCrunch

The software company was developed at Colossal Biosciences — known for its goal to bring extinct critters like the wooly mammoth back to life — and is now striking out on its own. As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform.

Biotech 240
article thumbnail

The Week’s 10 Biggest Funding Rounds: Obsidian Therapeutics And Flip Headline Another Strong Week

Crunchbase News

Biotech took center stage, notching three of the top four rounds. Obsidian Therapeutics , $161M, biotech: It was another big week for biotech startups raising huge sums of cash. Obsidian is a clinical-stage biotechnology company developing engineered cell and gene therapies.

Biotech 88